CMND
Clearmind Medicine·NASDAQ
--
--(--)
--
--(--)
CMND Filings
Filing Date
Form Description
Form Type
2026-03-31
Form EFFECT - Notice of Effectiveness
2026-03-31 ·
Form EFFECT - Notice of Effectiveness
2026-03-31
Form EFFECT - Notice of Effectiveness
2026-03-31 ·
Form EFFECT - Notice of Effectiveness
2026-03-30
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-30 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-27
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-27 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-25
Form POS AM - Post-Effective amendments for registration statement
2026-03-25 ·
Form POS AM - Post-Effective amendments for registration statement
2026-03-25
Form POS AM - Post-Effective amendments for registration statement
2026-03-25 ·
Form POS AM - Post-Effective amendments for registration statement
2026-03-19
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-19 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-17
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-17 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-16
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-16 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-16
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-16 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
